Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11009716 | Vaccine | 2018 | 7 Pages |
Abstract
These data show that there is room to improve both vaccination acceptance and advocacy rates in European HCWs, which would be expected to lead to higher rates of HCW vaccination. Benefits that could be expected from such an outcome are improved advocacy and better control of morbidity and mortality related to seasonal influenza infection.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
George Kassianos, Ernest Kuchar, Aneta Nitsch-Osuch, Jan Kyncl, Andrey Galev, Isme Humolli, Oana Falup-Pecurariu, Angus Thomson, Christina Klein, Gaëlle Vallée-Tourangeau,